RHT — Resonance Health Share Price
0.000.00%
Last trade - 00:00- AU$17.01m
- AU$17.09m
- AU$8.80m
- 59
- 70
- 25
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.69 | ||
| Price to Tang. Book | 49.31 | ||
| Price to Free Cashflow | 7.6 | ||
| Price to Sales | 1.59 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.4% | ||
| Return on Equity | -3.11% | ||
| Operating Margin | -14.01% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 3.71 | 3.82 | 3.83 | 4.51 | 8.8 | n/a | n/a | 19.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Resonance Health Limited is an Australia-based MedTech company. The Company specializes in the development and delivery of non-invasive medical imaging software and services. The Company is engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI) powered products to partner with clinicians and radiologists for diagnosis, and management of patients in a variety of clinical settings. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company's other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. The Company also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart.
Directors
- Martin Blake NEC
- Nick Allan CFO
- Timothy St. Pierre CSO
- Mitchell Wells EDR (45)
- Simon Panton NED
- Travis Baroni NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 19th, 1987
- Public Since
- October 23rd, 1987
- No. of Shareholders
- 1,809
- No. of Employees
- 18
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 459,616,138
- Address
- Ground Floor, SE 2 141 Burswood Road, PERTH, 6100
- Web
- https://www.resonancehealth.com/
- Phone
- +61 892865300
- Auditors
- HLB Mann Judd
Upcoming Events for RHT
Similar to RHT
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
What is the Resonance Health share price?
As of Today at 22:55 UTC, shares in Resonance Health are trading at AU$0.04. This share price information is delayed by 15 minutes.
How has the Resonance Health share price performed this year?
Shares in Resonance Health last closed at AU$0.04 and the price had moved by -55.95% over the past 365 days. In terms of relative price strength the Resonance Health share price has underperformed the ASX All Ordinaries Index by -56.61% over the past year.
What are the analyst and broker recommendations for Resonance Health?
There is no consensus recommendation for this security.
Find out moreWhat is the Resonance Health dividend yield?
Resonance Health does not currently pay a dividend.
Does Resonance Health pay a dividend?
Resonance Health does not currently pay a dividend.
When does Resonance Health next pay dividends?
Resonance Health does not currently pay a dividend.
How do I buy Resonance Health shares?
To buy shares in Resonance Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Resonance Health?
As of the previous close price of AU$0.04, shares in Resonance Health had a market capitalisation of AU$17.01m.
Where are Resonance Health shares listed?
Here are the trading details for Resonance Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: RHT
What kind of share is Resonance Health?
Based on an overall assessment of its quality, value and momentum Resonance Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Resonance Health share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Resonance Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Resonance Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -31.41%.
As of the last closing price of AU$0.04, shares in Resonance Health were trading -33.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Resonance Health PE Ratio?
The Resonance Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Resonance Health?
Resonance Health's management team is headed by:
- Martin Blake - NEC
- Nick Allan - CFO
- Timothy St. Pierre - CSO
- Mitchell Wells - EDR
- Simon Panton - NED
- Travis Baroni - NID